Intractable Epilepsy Clinical Trial
— EXPRESON-INOfficial title:
EXPRESON-INTRA : Intracerebral Recordings of P3a Responses to Own-names Uttered by Expressive and Neutral Voices in Pharmacoresistant Epilepsy Adult Patients
Verified date | January 2021 |
Source | Centre Hospitalier St Anne |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Neurophysiologic evaluation of disorders of consciousness (DOC) patients in intensive care unit include late auditory evoked potentials. It allows the physicians to record cerebral responses of patients to auditory stimuli and in particularly to their own name (as the P3a response). Numerous studies try to improve the relevance of the auditory stimuli used in this paradigm and notably using more expressive stimuli. Here the investigators investigate the intracerebral correlates of the P3a responses recorded on the scalp with neutral and more expressive stimuli.
Status | Active, not recruiting |
Enrollment | 20 |
Est. completion date | September 9, 2023 |
Est. primary completion date | September 9, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Intractable focal epilepsy with undergoing pre-surgical evaluation - intracerebral electrodes implantation in auditory cortices, temporal lobe, superior temporal gyrus, limbic areas, frontal lobe - Given Consent to inclusion Exclusion Criteria: - Deafness - Pregnancy |
Country | Name | City | State |
---|---|---|---|
France | GHU Paris - Sainte Anne | Paris |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier St Anne |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Latencies cartography of intracranial responses to own-name uttered by neutral voice | Analyse of latencies of intracranial responses recorded to own-name uttered by neutral voice to build a map of the brain process of this responses | 1 year | |
Primary | Latencies cartography of intracranial responses to own-name uttered by expressive voices | Analyse of latencies of intracranial responses recorded to own-name uttered by expressive voices to build a map of the brain process of this responses | 1 year | |
Secondary | Comparison between brain responses to own-name uttered by expressive voices recorded with intracerebral electrodes versus scalp electrodes | Qualitative comparison between scalp and intracranial recordings with the expressive voices paradigms (comparison of the latencies of the recorded responses) | 1 year | |
Secondary | Comparison between brain responses to own-name uttered by neutral voices recorded with intracerebral electrodes versus scalp electrodes | Qualitative comparison between scalp and intracranial recordings with the neutral voices paradigms (comparison of the latencies of the recorded responses) | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT00647322 -
The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
|
Phase 4 | |
Recruiting |
NCT02846272 -
Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation
|
N/A | |
Terminated |
NCT03955432 -
Long-term Cardiac Monitoring in Epilepsy
|
N/A | |
Completed |
NCT03860298 -
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy
|
N/A | |
Active, not recruiting |
NCT03916848 -
Novel Network Analysis of Intracranial Stereoelectroencephalography
|
N/A | |
Completed |
NCT03196271 -
Ketogenic Diet Drink Study
|
N/A | |
Recruiting |
NCT04219995 -
Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy
|
Phase 1/Phase 2 | |
Terminated |
NCT04650204 -
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
|
Phase 4 | |
Recruiting |
NCT05600738 -
Network Effects of Therapeutic Deep Brain Stimulation
|
N/A | |
Withdrawn |
NCT02934854 -
Biomarker for Creatine Deficiency Syndromes (BioCDS)
|
||
Completed |
NCT02915211 -
Evaluation of Keyo in Children With Epilepsy
|
N/A |